EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C

Benedikt Strunz iD, Qiuyao Zhan, Tanvi Khera, Julia Hengst, Marija Jankovic iD, Katja Deterding, Annika Niehrs iD, Markus Cornberg, Cheng-Jian Xu, Heiner Wedemeyer iD, Niklas K Björkström iD, HepNet Acute HCV IV Study Group

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Benedikt Strunz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Killer Cells, Natural, Hepatitis C, Lymphocyte Activation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, European Union's Horizon Europe Framework Programme, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute infection with hepatitis C virus (HCV) is a rare event that can be treated successfully with direct-acting antivirals (DAAs). As natural killer (NK) cells play an important role during the natural course of acute HCV, we assessed the NK cell compartment via flow cytometry and single-cell sequencing in longitudinally sampled patients with acute HCV and compared this to healthy controls and patients with chronic HCV. At the transcriptomic level, we identified a subset of highly activated NK cells with a robust type I interferon imprint. While the population of activated NK cells vanished after DAA-mediated cure, a long-term phenotypic imprint of infection was observed in comparison to healthy controls. Collectively, these data suggest an interferon-driven rise of an activated NK cell population during acute hepatitis C that is largely restored upon viral clearance. This study provides insights into the immunological basis for successful antiviral response to hepatitis C.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalHepatitis CLymphocyte ActivationHumansAntiviral AgentsHepacivirusMaleFemaleFlow CytometryMiddle AgedAdultAcute DiseaseSingle-Cell AnalysisLongitudinal Studies

Stichwörter der Autor:innen

NK cellsacute hepatitis Csingle-cell RNA sequencing

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Centre for Individualised Infection Medicine (CIIM), Helmholtz-Centre for Infection Research (HZI) and Hannover Medical School, Hannover, Germany.
  • TWINCORE, Centre for Experimental and Clinical Infection Research, Helmholtz-Centre for Infection Research (HZI) and Hannover Medical School, Hannover, Germany.
  • Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Braunschweig, Germany.
  • Cluster of Excellence RESIST (EXC2155), Hannover Medical School, Hannover, Germany.

ORCID-Profile: Benedikt Strunz, Marija Jankovic, Annika Niehrs, Heiner Wedemeyer, Niklas K Björkström

Förderung

  • European Research Council
  • European Union's Horizon Europe Framework Programme
  • Swedish Research Council
  • Swedish Cancer Society
  • Swedish Foundation for Strategic Research
  • Knut and Alice Wallenberg Foundation
  • Center for Innovative Medicine
  • Karolinska Institutet

Zitieren

APA

Strunz, B., Zhan, Q., Khera, T., Hengst, J., Jankovic, M., Deterding, K., Niehrs, A., Cornberg, M., Xu, C. J., Wedemeyer, H., Björkström, N. K., & HepNet Acute HCV IV Study Group (2025). Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf654

Vancouver

Strunz B, Zhan Q, Khera T, Hengst J, Jankovic M, Deterding K, et al. Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf654

BibTeX
@article{Strunz2025,
  author = {Strunz, Benedikt and Zhan, Qiuyao and Khera, Tanvi and Hengst, Julia and Jankovic, Marija and Deterding, Katja and Niehrs, Annika and Cornberg, Markus and Xu, Cheng-Jian and Wedemeyer, Heiner and Björkström, Niklas K and HepNet Acute HCV IV Study Group, HepNet Acute HCV IV Study Group},
  title = {Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf654}
}
Kostenlos starten →